. Author manuscript; available in PMC: 2015 Dec 1.

Published in final edited form as: Int J Immunogenet. 2014 Oct 29;41(6):521–527. doi: 10.1111/iji.12158

Table 2.

Univariate analysis

Univariate Probability of Outcomes for GTG (Hap1) distribution
Outcome	no GTG		one GTG		GTG/GTG		Pointwise p-value
Outcome	n	Prob (95% CI)	n	Prob (95% CI)	n	Prob (95% CI)	Pointwise p-value
Survival	275		242		58		0.31^a
@ 5 years		45 (40–51)		48 (41–54)		49 (36–62)	0.82
NRM	270		239		57
@ 5 years		41 (35–47)		40 (34–46)		39 (27–52)	0.96
Relapse	270		239		57
@ 5 years		16 (12–21)		16 (12–21)		14 (6–24)	0.90
AGVHD II-IV	272		239		58
@ 100 days		51 (45–57)		55 (49–61)		69 (57–80)	0.03
AGVHD III-IV	264		233		54
@ 100 days		25 (20–30)		23 (18–28)		22 (12–34)	0.86
CGVHD II-IV	273		241		56
@ 1 year		50 (44–56)		48 (42–55)		68 (55–79)	0.02

Univariate Probability of Outcomes for GTA (Hap2) distribution
Outcome	no GTA		one GTA		GTA/GTA		Pointwise p-value
Outcome	n	Prob (95% CI)	n	Prob (95% CI)	n	Prob (95% CI)	Pointwise p-value
Survival	305		225		45		0.47^a
@ 5 years		47 (42–53)		46 (40–53)		44 (30–59)	0.93
NRM	300		223		43
@ 5 years		42 (36–48)		39 (33–45)		38 (24–53)	0.74
Relapse	300		223		43
@ 5 years		12 (9–16)		19 (15–25)		24 (12–38)	0.03
AGVHD II-IV	302		222		45
@ 100 days		56 (50–61)		55 (48–61)		44 (30–59)	0.36
AGVHD III-IV	292		215		44
@ 100 days		25 (20–30)		24 (19–30)		14 (5–25)	0.14
CGVHD II-IV	303		223		44
@ 1 year		51 (45–57)		52 (45–59)		49 (34–64)	0.92

Univariate Probability of Outcomes for TTA (Hap3) distribution
Outcome	no TTA		one TTA			TTA/TTA	Pointwise p-value
Outcome	n	Prob (95% CI)	n	Prob (95% CI)	n	Prob (95% CI)	Pointwise p-value
Survival	434		135		6		0.39^a
@ 5 years		46 (41–50)		51 (43–59)		33 (5–72)	0.43
NRM	429		131		6
@ 5 years		41 (36–45)		39 (31–47)		67 (28–95)	0.37
Relapse	429		131		6
@ 5 years		17 (14–21)		13 (8–20)		0 (.-.)	N/A
AGVHD II-IV	429		134		6
@ 100 days		56 (51–61)		49 (40–57)		67 (28–95)	0.24
AGVHD III-IV	415		130		6
@ 100 days		23 (19–27)		25 (18–32)		33 (5–72)	0.83
CGVHD II-IV	430		134		6
@ 1 year		52 (47–57)		50 (41–58)		33 (5–72)	0.58

Univariate Probability of Outcomes for GCA (Hap4) distribution
Outcome	no GCA		one GCA		GCA/GCA		Pointwise p-value
Outcome	n	Prob (95% CI)	n	Prob (95% CI)	n	Prob (95% CI)	Pointwise p-value
Survival	292		236		47		0.62^a
@ 5 years		48 (42–54)		47 (41–53)		39 (25–54)	0.53
NRM	286		233		47
@ 5 years		39 (33–45)		41 (34–47)		47 (33–62)	0.56
Relapse	286		233		47
@ 5 years		18 (14–23)		14 (10–19)		13 (5–25)	0.38
AGVHD II-IV	290		233		46
@ 100 days		56 (50–61)		53 (47–60)		54 (40–68)	0.87
AGVHD III-IV	280		226		45
@ 100 days		22 (17–27)		23 (18–29)		33 (20–48)	0.32
CGVHD II-IV	287		236		47
@ 1 year		53 (47–58)		51 (44–57)		45 (31–59)	0.59

Abbreviations: Prob = Probability (%); CI = Confidence interval

Log-rank p-value